Prospective, Multicenter, Single-Arm, Phase Ⅱ Clinical Study on the Efficacy and Safety of Sacituzumab Tirumotecan Combined With Bevacizumab in Platinum-Resistant Recurrent Ovarian Cancer

Name: Prospective, Multicenter, Single-Arm, Phase Ⅱ Clinical Study on the Efficacy and Safety of Sacituzumab Tirumotecan Combined With Bevacizumab in Platinum-Resistant Recurrent Ovarian Cancer
Published: 2025
License: Public Domain

The First Affiliated Hospital of Zhengzhou University · 2025

ClinicalTrials.gov · Datasets · License: Public Domain · 2025

Open Source ↗

platinum-resistant recurrent ovarian cancer (proc), interventional, phase2

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Prospective, Multicenter, Single-Arm, Phase Ⅱ Clinical Study on the Efficacy and Safety of Sacituzumab Tirumotecan Combined With Bevacizumab in Platinum-Resistant Recurrent Ovarian Cancer

Related documents